Adaptimmune and GSK’s novel T-cell therapy works in solid tumours
Adaptimmune has more good news from its SPEAR T-cell therapy, yesterday unveiling encouraging early results in four patients with myxoid/round cell liposarcoma (MRCLS).
X
Adaptimmune and GSK’s novel T-cell therapy works in solid tumours
https://pharmaphorum.com/news/adaptimmune-gsks-novel-t-cell-therapy-works-solid-tumours/
